Latest news with #Medtech


AsiaOne
8 hours ago
- Business
- AsiaOne
Eye care giant Alcon keeps 'lens' on the future with expanded manufacturing and logistics facility in Tuas, Singapore News
Eye care-device giant Alcon officially opened its expanded state-of-the art manufacturing and logistics facility in Tuas Biomedical Park on Friday (June 27) morning. This brings Alcon's investments in Singapore to more than US$600 million (S$765 million) since it began operations in Singapore back in 2005. The completed Tuas facility is one of the Swiss-American firm's largest high-tech manufacturing sites with Industry 4.0 capabilities, advanced automation and smart manufacturing systems to meet the increasing global demand for its contact lenses. Amid a growing middle class and rising demand for quality healthcare, the Asia-Pacific region continues to be the fastest-growing market for medical technology, with its market value projected to reach nearly S$300 billion by 2030. This puts the region second only to the US as a source of demand for medical technology (Medtech). "Singapore is home to some of the world's best-in-class Medtech manufacturing palnts. The sector has been growing steadily, with a manufacturing output of S$19.4 billion in 2023. This marks a $5.2 billion increase over the past decade," said Senior Minister of State for Trade and Industry Low Yen Ling at the opening ceremony of Alcon's expanded facility. Beyond strengthening innovation and supply chain resilience within Singapore's MedTech ecosystem, Alcon's investment is also expected to benefit Singaporean workers and small- and medium-sized enterprises (SMEs) in Singapore. Muhammad Haiqal Bin Sapuan, an associate supervisor at Alcon made the switch from the oil and gas industry, through the Career Conversion Programme (CCP), in 2022 to have more time with his family. A year and a half into his role as a senior technician, he was nominated by his peers to step up as an associate supervisor. [[nid:707984]] "That recognition gave me confidence. I started off as an interim, and it was tough at first, but the team's support made the difference," said Haiqal. To date, nearly 180 Singaporean workers have benefitted from the CCP to become Alcon associates. Alcon's new facility is expected to create new job opportunities in production operations, quality control and supply chain management. It is also expected to strengthen innovation and supply chain resilience within Singapore's Medtech ecosystem through initiatives such as the Partnership for Capability Transformation, which partners local SMEs to buiild capabilities from precision moulding to packaging, helping them to scale and compete globally. [[nid:715407]] editor@
Yahoo
2 days ago
- Business
- Yahoo
Scanfil Strengthens its Customer Portfolio in Medtech & Life Science by Signing Agreement with Liquid Instruments
MELBOURNE, Australia, June 26, 2025--(BUSINESS WIRE)--Scanfil and Liquid Instruments have signed a manufacturing outsourcing agreement for Scanfil's Melbourne plant in Australia. This agreement supports Liquid Instruments' strategy to onshore production of its flagship Moku platform, strengthening domestic supply chains and bringing manufacturing closer to its research and development hub. "We're continuing to expand our manufacturing footprint in Australia," says Daniel Shaddock, CEO of Liquid Instruments. "Onshoring production through this partnership allows us to scale more efficiently, while deepening our investment in Australia's technology ecosystem. Scanfil's expertise and strong local presence make them the ideal partner for this next phase of growth." The collaboration will leverage Scanfil's and its subsidiary, SRXGlobal's, expertise in Medtech & Life Science. Liquid Instruments will benefit from supply chain management, scalable manufacturing, global delivery capabilities, and aftermarket services — all in Victoria, Australia. "Liquid Instruments has developed a unique product with an interesting and complex technology that is a perfect fit for the services provided by SRXGlobal in Australia. We at Scanfil and SRXGlobal are thrilled and excited that Liquid Instruments has chosen SRXGlobal as their preferred manufacturing partner for the exciting journey ahead, and we look forward to a strong and successful partnership", states Christian Kesten, VP of Scanfil APAC. Scanfil in brief Scanfil plc is Europe's largest listed provider of electronics manufacturing services (EMS), whose turnover in 2024 amounted to EUR 780 million. The company serves global sector leaders in the customer segments of Industrial, Energy & Cleantech, and Medtech & Life Science. The company's services include design services, prototype manufacture, design for manufacturability (DFM) services, test development, supply chain and logistics services, circuit board assembly, manufacture of subsystems and components, and complex systems integration services. Scanfil's objective is to grow customer value by improving their competitiveness and by being their primary supply chain partner and long-term manufacturing partner internationally. Scanfil's longest-standing customer account has continued for more than 40 years. The company has global supply capabilities and eleven production facilities across four continents. View source version on Contacts Further information:Christian KestenVice President, APAC regiontel. +86 512 67168867 Pasi HiedanpääDirector, Investor Relations and Communicationstel. +358 50 378 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Miami Herald
3 days ago
- Health
- Miami Herald
Bacteria that can cause vomiting, diarrhea gets kids' cough syrup recalled
Parents, guardians and all who care for kids should check their medicine cabinets after a children's cough syrup was recalled for a foodborne bacteria that can cause myriad problems. And, in extreme cases, cause death. Medtech Products' recall notice, posted to the FDA website, said it recalled five lots of Little Remedies Honey Cough Syrup for the 'presence of Bacillus cereus and loss of shelf-stability.' That bacteria can bring on two kinds of foodborne illnesses. 'One type is characterized by nausea, vomiting, and stomach cramps that can start one to six hours after eating or drinking contaminated food,' Medtech's notice said. 'The second type can cause stomach cramps and diarrhea that can start eight to 16 hours after eating or drinking contaminated food. 'Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death.' Recalled lot Nos. are 0039, expiration date 11/2025; 0545, expiration date 1/2026; 0640, expiration date 2/2026; 0450, expiration date 5/2026; and 1198, expiration date 12/2026. For refunds, Medtech is asking customers to go to the Prestige Brands website, email medicalaffairs@ or call 800-754-8853, Monday through Friday, 8:30 a.m. to 5:30 p.m., Eastern time. Any medical problems should be taken to a medical professional first. Then notify the FDA's MedWatch program by filling out a report online. After that, tell Medtech.


Irish Post
17-06-2025
- Business
- Irish Post
Minister attends opening of leading Irish medtech firm's new manufacturing facility
A LEADING Irish medtech firm has opened a new state-of-the-art manufacturing facility in Co. Galway to increase production on one of its leading products. Neurent Medical has produced a non-surgical solution for people suffering with chronic rhinitis - a persistent inflammation of the nasal passages, which can cause symptoms such as a runny nose, nasal congestion, and post-nasal drip for more than 12 weeks. Their product Neuromark targets the underlying drivers of the condition so effectively that there is growing demand for the technology both in Ireland and in the US. To meet demand, the firm has launched its new manufacturing site at Westlink Commercial Park in Oranmore. Pictured (l-r) Minister Hildegarde Naughton, Jenny Melia of Enterprise Ireland and Brian Shields, CEO Neurent Medical 'We're proud to scale our operations in Galway, where the MedTech ecosystem continues to thrive,' Neurent Medical CEO Brian Shields said. 'Our new Westlink facility gives us the manufacturing capacity to meet growing demand for Neuromark, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland.' He added: 'As an Irish-founded company, we're excited to manufacture our product locally with the exceptional skills available and deliver Irish-engineered MedTech innovation to the world.' The new facility will bring 125 new highly skilled jobs to the Galway area by the end of 2028, the company has confirmed. The new jobs will range across key functions in engineering, quality control, operations, supply chain management, and sales and marketing. Originating from the Enterprise Ireland-supported BioInnovate Ireland Programme, Neurent Medical has grown from concept to commercialisation within a decade, emerging as one of Ireland's medtech success stories. Minister Hildegarde Naughton and Jenny Melia, CEO (Designate) of Enterprise Ireland, who have supported the firm, were at the opening of the new site. 'I want to congratulate Neurent Medical on this significant achievement,' Minister Naighton said. 'Galway is known as a major player in medical technology, being home to eight of the world's top 10 medtech companies. 'As a native myself, I am particularly proud to see 125 new highly skilled jobs being created by a company based in Oranmore,' she added. 'It is also highly notable that this is an Irish company, supported by Enterprise Ireland, and selling into the US market. 'I have no doubt, given their impressive growth to date, that this will be but one of many major achievements for the company.' See More: Enterprise Ireland, Galway, Irish, Medtech, Neurent Medical


Time of India
27-05-2025
- Business
- Time of India
UPDF keen on launching projects
Lucknow: A delegation of the UP Diaspora Investors affiliated with the UP-Development Forum (UPDF) also participated in the Invest UP Round Table Conference held in Mumbai on Tuesday. Chairman Pankaj Jaiswal proposed an investor conclave in Lucknow and a roadshow in Dubai in partnership with UPDF to attract the diaspora and encourage investment in the state. He also made several announcements on behalf of his organisation. He said that Kapil Tiwari of the Shree Krishnanand Group has showed interest in the ready mix plaster plant in Lucknow and Noida. Once in place, the project would translate into an investment of Rs 25 crore. Jaiswal added that Rajiv Ranjan Singh of EN Communication was willing to build a Mahabharat Museum in the YIEDA area (near the upcoming international film city) with an investment of Rs 1,500 crore. He also stated that Arnav Gupta of Rimence DSP Infra submitted a proposal to expand its cold emulsion-based road patch mix plant in Lucknow with an investment of Rs 5 crore. In addition to this, Sachidanand Upadhyaya from Lords Group was willing to invest Rs 1,500 crore for setting up a factory for IVD/Medtech and Roof Top Solar. The list also included a proposal by Sachin Singh from Diasys India, who showed interest in expanding its existing plant to double its capacity with an investment of Rs 10 crore.